Search results
Lung cancer treatment produces progression-free survival results in Phase III trial
Medical Xpress· 2 days agoOsimertinib, produced by AstraZeneca under the brand name Tagrisso, significantly extends the time patients live without their cancer worsening, offering the first effective ...
Newswise Expert | Melinda Hsu , Case Western Reserve University
Newswise· 4 hours agoMy primary career objective is to investigate the experiences and optimize the care of long-term survivors of lung cancer patients. This interest has been ...
'I've battled skin cancer for 15 years after using sunbeds as a teenager'
Yahoo Life UK· 2 days agoSo then the slippery slope started of surgery, issues, treatments." Madden was later advised to have...
Six cancer treatment breakthroughs pushing us closer to a cure
The Telegraph via Yahoo News· 7 days agoWhat will it treat? PCNA is found in all cancers, and AOH1996 has shown promise in 70 cell lines,...
Engineered bacteria deliver chemotherapy directly to tumors
Medical Xpress· 15 hours agoNow, researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have developed a revolutionary approach to cancer treatment ...
Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates
The National Law Review· 1 day agoAntibody-drug conjugates (ADCs) are a promising class of cancer treatments with an accelerating...
New Lung Cancer Drug Trial Hailed As Best Result Ever, Setting A “New Benchmark”
IFLScience· 4 days agoPhase III trial results for a new drug targeting advanced lung cancer have just been reported, with...
City of Hope’s new blood test for lung cancer will mean more early detections
Los Angeles Daily News· 7 days agoTo test for lung cancer, a person needs to get low-dose computed tomography screening, more commonly...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
Reuters via AOL· 7 days agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
Bristol’s $250,000 Pill Slows Lung Cancer Growth by Seven Weeks
Bloomberg· 6 days agoHave a confidential tip for our reporters? A Bristol Myers Squibb Co. lung cancer treatment delayed...